Supplemental material
Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Open access
1,096
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
Shigeki Nakamuraa Department of Microbiology, Tokyo Medical University, Tokyo, Japan
https://orcid.org/0000-0001-5272-8886View further author information
Masashi Mikamib Health and Value, Pfizer Japan Inc., Tokyo, Japan
https://orcid.org/0000-0001-7731-847XView further author information
Tomoyuki Hayamizuc Vaccine Medical Affairs, Medical Japan, Pfizer Japan Inc., Tokyo, Japan
https://orcid.org/0009-0002-2989-4303View further author information
Naohiro Yonemotob Health and Value, Pfizer Japan Inc., Tokyo, Japan
https://orcid.org/0000-0003-3637-2095View further author information
Camille Moyond Health Economics and Outcomes Research, Putnam, Paris, FranceView further author information
, Mark Gouldsone Health Economics and Outcomes Research, Putnam, Westport, Ireland
https://orcid.org/0009-0006-7259-0881View further author information
Catriona Crossane Health Economics and Outcomes Research, Putnam, Westport, IrelandView further author information
, Jeffrey Vietrif Global Access and Value, Pfizer Inc., Collegeville, PA, USA
https://orcid.org/0000-0002-5610-3098View further author information
Kazumasa Kameib Health and Value, Pfizer Japan Inc., Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-7220-5142View further author information
Pages 546-560
|
Received 14 Feb 2024, Accepted 29 Apr 2024, Published online: 09 May 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.